LATEST ARTICLES
Canada
Torkin Manes LLP
As regulated health professionals, Ontario pharmacists owe a primary duty to the public. However, pressures within the profession are threatening to shift focus...
Osler, Hoskin & Harcourt LLP
Legislation for the period 03/21 to 04/10
Seastone IP
This year, an independent expert panel was appointed to conduct a legislative review of the Cannabis Act.
Smart & Biggar
On February 16, 2024, the Minister of Health tabled the 2022 Annual Report of the Patented Medicine Prices Review Board (PMPRB).
Smart & Biggar
On February 29, 2024, the Minister of Health announced the introduction of Bill C-64, An Act respecting pharmacare (Pharmacare Act), which "proposes the foundational principles...
Smart & Biggar
On February 23, 2024, Health Canada announced that it will expand the information available on the Generic Submissions Under Review (GSUR) list to include the following...
Smart & Biggar
In this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 update.
Osler, Hoskin & Harcourt LLP
On March 14, 2024, the province of British Columbia proposed broad multi-government class action legislation to claim costs arising from "health-related wrongs".
McCarthy Tétrault LLP
Health Canada has published its long anticipated notice regarding changes to the Generic Submissions Under Review (GSUR) List.
Oyen Wiggs Green & Mutala LLP
In Pharmascience Inc. v. Janssen Inc., 2024 FCA 10, the Federal Court of Appeal dismissed Pharmascience's appeal of a Federal Court decision that found Pharmascience's...
Gardiner Roberts LLP
In a follow-report released on March 14, 2024, the CBC states that it has received information from more than a dozen current and former Shoppers Drug Mart...
Bennett Jones LLP
Water management a high priority—Alberta's largest water-sharing effort ever is underway Drone use and data driving decision making
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Fasken
The federal Parliament tabled Bill C-64, An Act respecting pharmacare (the "Bill"), on February 29, 2024. The Bill outlines the first phase of the federal government's...
Fasken (French)
Le 26 janvier, Santé Canada a publié un avis précisant comment l'état « dormant » d'un médicament dans la base de données sur les produits pharmaceutiques...
McCarthy Tétrault LLP
Earlier this month, the NDP and the Liberals announced a deal to introduce the first piece of a national pharmacare program providing federal funding for medications for Canadians.
Gardiner Roberts LLP
An investigative report published yesterday on CBC.ca reveals that former Shoppers Drug Mart (SDM) employees are alleging that intense pressure from SDM...
Torys LLP
Agriculture has historically been among Canada's most important economic drivers. However, it is marked by unique challenges including changing environmental conditions...
Torys LLP
Cellular agriculture is considered a pioneering technology, which presents not only opportunities for resource security but a variety of uses beyond the food chain.
Torys LLP
Cellular agriculture is heralded as enabling food security and bringing more innovative products to consumers; however, there are still barriers to its adoption. What changes need to happen...
Mondaq Webinars
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Comparative Guides
Curated Content
Alberta Court Upholds Express Employee Agreement On Random Drug And Alcohol Testing
Stikeman Elliott LLP
Stikeman Elliott LLP
The CNESST Requires That Medical Masks Be Worn Continuously Indoors In Workplaces
Stikeman Elliott LLP
Stikeman Elliott LLP
Popular Contributors
Goodwin Procter LLP
United States
Turnpenny Milne
Canada
Fasken (French)
Canada
Upcoming Events
APR25
APR26
Panel New York United States
Mondaq Advice Centres
